Dear Sir, Please find attached Annual Secretarial Compliance Report for the Financial Year 2024-25

Omkar Pharmachem Ltd submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, as mandated under Regulation 24A(2) of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The report was prepared by M/s. Maulik Bhavsar & Associates, Practicing Company Secretaries, who reviewed the company's compliance with SEBI Act, SCRA, and various SEBI regulations including LODR, Insider Trading, and Depository rules. The auditor confirmed the company is compliant across all 13 examined areas — covering secretarial standards, policy adoption, website disclosures, director disqualification, related party transactions, insider trading, and event disclosures — with no deviations, penalties, or enforcement actions reported. No SEBI or stock exchange actions were taken against the company, its promoters, or directors during the year, and no statutory auditor resignations occurred.